Gregory Berk - Feb 16, 2021 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Director
Signature
/s/ Gregory Berk
Stock symbol
GTBP
Transactions as of
Feb 16, 2021
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 04:10 PM
Previous filing
Feb 14, 2022
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTBP Common Stock Award $0 +278K $0.00 278K Feb 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50K $0.00 50K Feb 16, 2021 Common Stock 50K $6.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of shares of restricted stock ("RSAs") in connection with the reporting person's services as a director. 1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022. The reporting person resigned as a director on April 23, 2021.
F2 Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023.